Navigation Links
Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting
Date:5/12/2008

of the Urgent PC system as compared to tolterodine LA, the leading pharmaceutical treatment for overactive bladder. The poster session will begin on Tuesday, May 20, 2008 at 1:40 p.m. ET.

Uroplasty Booth Presentations

Throughout the AUA conference, Uroplasty will host seven presentations at its Booth #3729. These include:

-- "Benefits of Urgent PC in Treating Patients with Urinary Symptoms," to

be presented by Elizabeth Bozeman, M.D., on Sunday, May 18 and Monday,

May 19 at 12:15 PM;

-- "Urgent PC and the Patient Refractory to Anticholinergic Drugs," to be

presented by Scott MacDiarmid, M.D., on Sunday, May 18 and Monday,

May 19 at 12:45 PM;

-- "Incorporating Urgent PC into a Community-Based Urology Practice," to

be presented by Judy Siegel, M.D., on Monday, May 19 at 2:15 PM and

Tuesday, May 20 at 12:15 PM;

-- "Macroplastique(R) in the Treatment of Female Stress Urinary

Incontinence," to be presented by Edward Gheiler, M.D., on Monday,

May 19 at 2:45 PM.

About the Urgent PC Neuromodulation System

The Urgent PC neuromodulation system is a proprietary, minimally invasive nerve stimulation device designed for office-based treatment of urge incontinence, urinary urgency and urinary frequency. Application of neuromodulation therapy targets specific nerve tissue and disrupts the signals that lead to these urinary symptoms. Uroplasty sells the Urgent PC system in the United States, Canada and countries recognizing the CE mark. Outside of the United States, the Urgent PC is also indicated for the treatment of fecal incontinence.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. O
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Uroplasty Plans to Double Sales Force During Fiscal 2009
2. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
3. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
4. Uroplasty Expands Marketing Program for Urology Practices
5. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock
6. Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter
7. Uroplasty to Host Second Quarter Conference Call on November 1
8. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
9. Highlights for APAs 116th Annual Convention in Boston, Aug. 14-17
10. Isis Reports Financial Results and Highlights for First Quarter of 2008
11. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wire/--TheBayAreaAirQualityManagementDistrictisiss... Alert forThursday,November26,2009whichbansbu...bothindoorsandoutdoors. ,, "Cold,stillweatherwi...kBroadbent,executiveofficeroftheAirDistrict."We,re...ghborsandfellowcommunitymembersthisThanksgiving,an...
(Date:11/25/2009)...r cancer who were treated with cisplatin-based che...neurological side effects and Raynaud-like phenome...y, according to a new study published online Novem...itute . , Marianne Brydy, M.D., of the Departmen...ergen, Norway, and colleagues conducted a cross-se...
(Date:11/25/2009)...ew out of a collaboration between UCLA engineers a...nearly 10 million Americans who suffer from periph...ning of the arteries, peripheral arterial disease,...narrowed arteries reduce blood flow to the limbs. ...r disease, heart attack and stroke, and its progre...
(Date:11/25/2009)... short to draw definite conclusions, experts say,... -- In diabetic patients with blocked coronary art...es at one year whether patients undergo bypass sur...hers report. , Bypass surgery has been the stan... artery disease. However, less invasive approaches...
(Date:11/25/2009)...on and treatment clinics to resume Monday, Nov. 30...mber 25, 2009 -- Centegra Health System is continu...shots at four Centegra Primary Care (CPC) vaccinat...arrived. The clinics are at CPC sites in Huntley, ...en as follows: ,   From 4:30 to 7:30 p...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...nt on incorporating the patient’s voice into cance...estigators have sought out the best //practices, p...lity of life (QOL) assessment. Their findings were...sychological, emotional, social and spiritual well...
...st-published research study by Dr. R Preston Mason... that astaxanthin, a relatively //unknown caroteno... viable scaffold for a new therapy to treat cardio...necdotal human data, the results of the Mason stud...
...ary is Alzheimer Awareness Month. Two experts from... are available to comment on the effects of Alzhei... on risk factors and potential cures. The availabi...ians aged 65 and over have AD. As populations arou...
...nty-four percent of men treated with a combination...ation therapy for prostate cancer are cured of the...ording to a study. // This study was conducte... two different types of radiation therapy, to prol...
...millions of Americans afflicted with Type 1 and 2 ...ing: heart and kidney disease; //nerve damage and ...al disorders and hypoglycemia. Another major ...e sensitive area at the back of the eye). Overall,...
...e millions of Americans place fitness as one of th...uscle tone and overall appearance, cancer survivor...s at The University of Texas M. D. Anderson Cancer... bay. Karen Basen-Engquist, Ph.D., principal inves...
Other Medicine News:Health News:Better Understanding of Quality of Life Assessments 2Health News:Better Understanding of Quality of Life Assessments 3Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3Health News:Alzheimer’s Disease: Let’s Weigh-In on the Ris 2Health News:Vision Loss Can Be Prevented in People With Diabetes 2Health News:Vision Loss Can Be Prevented in People With Diabetes 3Health News:The Shape of Health to Come 2
(Date:11/25/2009)...TrendsResearchGroup,Inc.releasedWave1ofits Launch...asesyndicatedmarketresearchprojecttrackingthelaunc...hthroughthefirstsixmonthsofavailability.Eachwaveof...ueDermatologistsandqualitativeinformationfromasubs...lestouse,typicalpatienttypes,productperceptions,pr...
(Date:11/25/2009)...re/--RegadoBiosciences,aprivatelyheldcompanyleadin...ontrolagents,announcedthatDavidMazzo,PhD,CEOandPre...HealthCareConferenceattheNewYorkPalaceHotelinNewYo...ST)onTuesday,December1andwillincludeanoverviewofth...program,theanticoagulantsystem,REG1.Thehealthcarei...
(Date:11/25/2009)...ire/--SwissrayInternational,Inc.aleadingmanufactur...edtodaythatitsoperationshavebeenacquiredbyaprivate...ay,smedicalimagingbrand.Theacquisitionincludedalla...nventory.After25yearsofsuccessandgrowthSwissrayisn...mentswithstableandsteadygrowth. ,, "Swissrayhas...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Parameter Generation and Control Launches New Catalog 26quot 3BPharmaceutical Stability Solutions 26quot 3B 14328 1Parameter Generation and Control Launches New Catalog 26quot 3BPharmaceutical Stability Solutions 26quot 3B 14328 2Major Central Florida Label Printer Creates On Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers 58739 1Major Central Florida Label Printer Creates On Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers 58739 2Major Central Florida Label Printer Creates On Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers 58739 3Your Eyes May Help Diagnose Heart Disease and Stroke 58736 1Your Eyes May Help Diagnose Heart Disease and Stroke 58736 2Your Eyes May Help Diagnose Heart Disease and Stroke 58736 3
...., May 5 Vaccines don,t just keep children,health... who can earn,higher wages and save more money, ac...t the Harvard School of Public Health., Bloom, wh...n developing,countries, will be the keynote speake...h sponsored by the National Foundation for Infecti...
...o., May 5 N30 Pharma (N30), a,biopharmaceutical c...commercialization of drugs that target endogenous ...sfully completed Phase I study of N30-201,in patie...hy volunteers.,N30 intends to develop N30-201 for ...iseases, including Cystic Fibrosis and asthma., "...
Other Medicine Technology:Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 2Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 3Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 4Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 5Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 6N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 2
...LARK CLOtest Rapid Urease Test is recognized by me...ease tests because of its accuracy, convenience an...rshall, MD. who, along with Robin Warren, M.D. was...pylori and gastric ulcers. Today, CLOtest has beco...
SERIM PYLORITEK VP TEST KIT
...ue H.pylori gII test is a lateral-flow immuno-chro...ive detection of IgG antibodies specific to Helico...d. It utilizes a convenient, non-invasive, and eas... the diagnosis of H.pylori infection in patients w...
...P is a visually read, qualitative immunochromatogr...H. pylori, a bacterium that grows in the stomach a...e gastric cancers. FlexSure HP, available for use ... the physician with the opportunity to perform "on...
Medicine Products: